Latest Threads

On 19th September 2024, GFH Financial Group B.S.C. announced that discussions and negotiations are ongoing for the acquisition of Ithmaar Holding B.S.C.'s financing and investment portfolios, subject to regulatory approvals. Shareholders will be regularly updated on any further developments. The expected financial impact will be disclosed in due course. Previous related disclosures were made on 6th March, 7th April, 6th May, and 6th June 2024. The announcement was signed by Mariam Jowhary, Head of Compliance & AML.

The "Sustainability Report 2023" focuses on accelerating growth while ensuring environmental stewardship, social well-being, and ethical governance.

The 2023 Sustainability Report focuses on accelerating growth while ensuring environmental stewardship, social well-being, and ethical governance.

Abu Dhabi Stem Cells Center (ADSCC) and Burjeel Holdings PLC have formed a strategic partnership to expand bone marrow transplant and cellular therapy services at Burjeel Medical City (BMC). This collaboration aims to enhance access to advanced care for patients with blood cancer, genetic diseases, autoimmune diseases, and other conditions, establishing Abu Dhabi as a global healthcare destination. ADSCC will extend its proprietary Abu Dhabi Bone Marrow Transplant Program (AD-BMT©) to BMC, which is accredited by the Department of Health - Abu Dhabi and recognized by the Foundation for the Accreditation of Cellular Therapy (FACT). ADSCC has achieved significant milestones in bone marrow transplantation and CAR-T Cell Therapy since 2020. The Burjeel Cancer Institute (BCI) at BMC has also pioneered bone marrow transplants, including the UAE’s first pediatric BMT in 2022. The partnership aims to create an integrated ecosystem for advanced research, cellular therapy, and regenerative medicine, benefiting new and existing patients. Both institutions are committed to setting new benchmarks in patient outcomes and medical excellence.